Follow
Manfred Claassen
Manfred Claassen
University of Tübingen / University Hospital of Tübingen
Verified email at med.uni-tuebingen.de
Title
Cited by
Cited by
Year
The quantitative proteome of a human cell line
M Beck, A Schmidt, J Malmstroem, M Claassen, A Ori, A Szymborska, ...
Molecular systems biology 7 (1), 549, 2011
8092011
Protein identification false discovery rates for very large proteomics data sets generated by tandem mass spectrometry
L Reiter, M Claassen, SP Schrimpf, M Jovanovic, A Schmidt, JM Buhmann, ...
Molecular & Cellular Proteomics 8 (11), 2405-2417, 2009
3302009
False discovery rate estimation for cross-linked peptides identified by mass spectrometry
T Walzthoeni, M Claassen, A Leitner, F Herzog, S Bohn, F Förster, M Beck, ...
Nature methods 9 (9), 901-903, 2012
2722012
Cell-wide analysis of protein thermal unfolding reveals determinants of thermostability
P Leuenberger, S Ganscha, A Kahraman, V Cappelletti, PJ Boersema, ...
Science 355 (6327), eaai7825, 2017
2542017
Automated Gleason grading of prostate cancer tissue microarrays via deep learning
E Arvaniti, KS Fricker, M Moret, N Rupp, T Hermanns, C Fankhauser, ...
Scientific reports 8 (1), 1-11, 2018
2242018
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...
Nature 592 (7854), 450-456, 2021
2072021
The Mtb proteome library: a resource of assays to quantify the complete proteome of Mycobacterium tuberculosis
OT Schubert, J Mouritsen, C Ludwig, HL Röst, G Rosenberger, PK Arthur, ...
Cell host & microbe 13 (5), 602-612, 2013
1762013
Estimation of absolute protein quantities of unlabeled samples by selected reaction monitoring mass spectrometry
C Ludwig, M Claassen, A Schmidt, R Aebersold
Molecular & Cellular Proteomics 11 (3), 2012
1442012
Directed mass spectrometry: towards hypothesis-driven proteomics
A Schmidt, M Claassen, R Aebersold
Current opinion in chemical biology 13 (5-6), 510-517, 2009
1162009
Absolute quantification of microbial proteomes at different states by directed mass spectrometry
A Schmidt, M Beck, J Malmström, H Lam, M Claassen, D Campbell, ...
Molecular systems biology 7 (1), 510, 2011
1072011
GM-CSF and CXCR4 define a T helper cell signature in multiple sclerosis
E Galli, FJ Hartmann, B Schreiner, F Ingelfinger, E Arvaniti, M Diebold, ...
Nature medicine 25 (8), 1290-1300, 2019
1062019
Nontargeted metabolomics reveals the multilevel response to antibiotic perturbations
M Zampieri, M Zimmermann, M Claassen, U Sauer
Cell reports 19 (6), 1214-1228, 2017
1042017
Comprehensive proteomics
M Beck, M Claassen, R Aebersold
Current opinion in biotechnology 22 (1), 3-8, 2011
962011
Sensitive detection of rare disease-associated cell subsets via representation learning
E Arvaniti, M Claassen
Nature communications 8 (1), 1-10, 2017
952017
The dynamics of root cap sloughing in Arabidopsis is regulated by peptide signalling
CL Shi, D Von Wangenheim, U Herrmann, M Wildhagen, I Kulik, A Kopf, ...
Nature Plants 4 (8), 596-604, 2018
422018
The SIB Swiss Institute of Bioinformatics’ resources: focus on curated databases
SIB Swiss Institute of Bioinformatics Members
Nucleic acids research 44 (D1), D27-D37, 2016
392016
Structure-function relationships of HDL in diabetes and coronary heart disease
M Cardner, M Yalcinkaya, S Goetze, E Luca, M Balaz, M Hunjadi, ...
JCI insight 5 (1), 2020
372020
Inference and validation of protein identifications
M Claassen
Molecular & cellular proteomics 11 (11), 1097-1104, 2012
342012
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia
S Kreutmair, S Unger, NG Núñez, F Ingelfinger, C Alberti, D De Feo, ...
Immunity 54 (7), 1578-1593. e5, 2021
312021
Similarities and differences of blood N-glycoproteins in five solid carcinomas at localized clinical stage analyzed by SWATH-MS
T Sajic, Y Liu, E Arvaniti, S Surinova, EG Williams, R Schiess, ...
Cell reports 23 (9), 2819-2831. e5, 2018
302018
The system can't perform the operation now. Try again later.
Articles 1–20